Long-term (2–5 years) adverse clinical outcomes associated with ZES versus SES, PES and EES: A Meta-Analysis

Several previously published trials comparing Zotarolimus Eluting Stents (ZES) with Sirolimus Eluting Stents (SES), Paclitaxel Eluting Stents (PES) or Everolimus Eluting Stents (EES) at a follow up period of 1 year, were continually being followed up in order to assess the long-term outcomes. In thi...

Descripción completa

Detalles Bibliográficos
Autores principales: Bundhun, Pravesh Kumar, Bhurtu, Akash, Pursun, Manish, Soogund, Mohammad Zafooruddin Sani, Teeluck, Abhishek Rishikesh, Huang, Wei-Qiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5527000/
https://www.ncbi.nlm.nih.gov/pubmed/28743907
http://dx.doi.org/10.1038/s41598-017-06705-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5527000/
https://www.ncbi.nlm.nih.gov/pubmed/28743907
http://dx.doi.org/10.1038/s41598-017-06705-y

Ejemplares similares